Submit Feedback
Recent searches
    Trending searches
    Agilent Technologies
    +
    Revenue breakdown by Products & Services
    Revenue breakdown by Geography

    Agilent Technologies's Revenue by Segment

    In fiscal year 2024, Agilent Technologies's revenue by segment (products & services) are as follows:

    • Agilent CrossLab: $1.64B
    • Diagnostics and Genomics: $1.65B
    • Life Sciences and Applied Markets: $3.22B

    Learn more about Agilent Technologies’s Revenue by Geography

    Check out competitors to Agilent Technologies in a side-by-side comparison.

    Explore additional financial metrics for Agilent Technologies.

    Continue reading...

    The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).

    In fiscal year 2022, Agilent Technologies's revenue by segment is as follows:

    • Agilent CrossLab generated $1.45B in revenue, representing 21.2% of its total revenue.
    • Diagnostics and Genomics generated $1.39B in revenue, representing 20.28% of its total revenue.
    • Life Sciences and Applied Markets generated $4.01B in revenue, representing 58.51% of its total revenue.

    The biggest segment for Agilent Technologies is the Life Sciences and Applied Markets, which represents 58.51% of its total revenue.
    The smallest segment for Agilent Technologies is the Diagnostics and Genomics, which represents 20.28% of its total revenue.

    The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).

    In fiscal year 2023, Agilent Technologies's revenue by segment is as follows:

    • Agilent CrossLab generated $1.57B in revenue, representing 22.95% of its total revenue.
    • Diagnostics and Genomics generated $1.41B in revenue, representing 20.62% of its total revenue.
    • Life Sciences and Applied Markets generated $3.86B in revenue, representing 56.43% of its total revenue.

    The biggest segment for Agilent Technologies is the Life Sciences and Applied Markets, which represents 56.43% of its total revenue.
    The smallest segment for Agilent Technologies is the Diagnostics and Genomics, which represents 20.62% of its total revenue.

    The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).

    In fiscal year 2024, Agilent Technologies's revenue by segment is as follows:

    • Agilent CrossLab generated $1.64B in revenue, representing 25.25% of its total revenue.
    • Diagnostics and Genomics generated $1.65B in revenue, representing 25.36% of its total revenue.
    • Life Sciences and Applied Markets generated $3.22B in revenue, representing 49.39% of its total revenue.

    The biggest segment for Agilent Technologies is the Life Sciences and Applied Markets, which represents 49.39% of its total revenue.
    The smallest segment for Agilent Technologies is the Agilent CrossLab, which represents 25.25% of its total revenue.
    Continue reading...

    Summary Table

    Products & Services (Percent Share) 2022 2023 2024
    Agilent CrossLab 21.2% 22.95% 25.25%
    Diagnostics and Genomics 20.28% 20.62% 25.36%
    Life Sciences and Applied Markets 58.51% 56.43% 49.39%
    Total Revenue 100% 100% 100%

    The above chart shows the revenue trend of different segments of Agilent Technologies.

    In fiscal year 2024, the Life Sciences and Applied Markets generated the most revenue ($3.22B), and the Agilent CrossLab generated the least revenue ($1.64B).

    The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Agilent CrossLab revenue increased 4.85% ($76.00M) from $1.57B (in 2023) to $1.64B (in 2024).
  • Diagnostics and Genomics revenue increased 17.18% ($242.00M) from $1.41B (in 2023) to $1.65B (in 2024).
  • Life Sciences and Applied Markets revenue decreased -16.62% ($641.00M) from $3.86B (in 2023) to $3.22B (in 2024).
    • Continue reading...

    Summary Table

    Products & Services 2022
    Value Change
    		2023
    Value Change
    		2024
    Value Change
    Agilent CrossLab $1.45B - $1.57B
    7.99%
    		$1.64B
    4.85%
    Diagnostics and Genomics $1.39B - $1.41B
    1.44%
    		$1.65B
    17.18%
    Life Sciences and Applied Markets $4.01B - $3.86B
    3.77%
    		$3.22B
    16.62%
    Total Revenue $6.85B - $6.83B
    0.22%
    		$6.51B
    4.73%

    Related company

    Related